- Report
- September 2024
- 250 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- August 2025
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
- Report
- May 2025
- 91 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- January 2025
- 111 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- July 2025
- 350 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- June 2025
- 400 Pages
Global
From €4322EUR$4,949USD£3,755GBP
- Report
- July 2025
- 133 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- January 2025
- 80 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- July 2025
- 83 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- June 2025
- 134 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- June 2025
- 130 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- May 2025
- 130 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- April 2025
- 140 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- February 2025
- 132 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- February 2025
Japan, United States, ... Japan, United States, Europe, Global
From €3275EUR$3,750USD£2,845GBP
- Report
- February 2025
- 130 Pages
Global
From €3600EUR$4,123USD£3,128GBP
€4236EUR$4,850USD£3,680GBP
- Report
- June 2025
- 250 Pages
United States
From €2436EUR$2,789USD£2,116GBP
- Report
- February 2025
Middle East
From €3930EUR$4,500USD£3,414GBP
- Report
- February 2025
North America, Mexico, ... North America, Mexico, Canada
From €2140EUR$2,450USD£1,859GBP
- Report
- February 2025
Germany, Italy, Spain, ... Germany, Italy, Spain, United Kingdom, Europe, France
From €2489EUR$2,850USD£2,162GBP

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones.
The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare.
Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more